4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-001520
Chief Commercial Officer sold 2,403 shares at an average $36.30 ($87,225)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Olinger Margaret Chief Commercial Officer | 2023-01-06 | Sale | +1,660 | $36.08 | $59,891 | 215,098 | D |
| Olinger Margaret Chief Commercial Officer | 2023-01-06 | Sale | +743 | $36.79 | $27,334 | 214,355 | D |
| Open-market sales · 2,403 sh · avg $36.30 · $87,225 | |||||||
Loading xslF345X03/doc4.xml…